136 related articles for article (PubMed ID: 35135482)
1. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
2. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
3. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
5. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
Abu Zaid M; Dinh PC; Monahan PO; Fung C; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Sesso HD; Huddart R; Mushiroda T; Kubo M; Dolan ME; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2019 May; 17(5):459-468. PubMed ID: 31085753
[TBL] [Abstract][Full Text] [Related]
6. What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention.
Poniatowska G; Michalski W; Kucharz J; Jonska-Gmyrek J; Wieszczy P; Nietupski K; Demkow T; Dedecjus M; Sadowska M; Kalinowski T; Grochulska-Nalazek B; Nowatorska A; Stelmasiak P; Wiechno PJ
Med Oncol; 2020 Aug; 37(9):82. PubMed ID: 32767179
[TBL] [Abstract][Full Text] [Related]
7. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism risk in men treated for childhood cancer.
Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4180-6. PubMed ID: 19789207
[TBL] [Abstract][Full Text] [Related]
9. Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
Isaksson S; Bogefors K; Åkesson K; Øra I; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Osteoporos Int; 2020 Jul; 31(7):1261-1272. PubMed ID: 32008156
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Gonadal Function and Cardiometabolic Risk in Young Men With Chronic Spinal Cord Injury.
Sullivan SD; Nash MS; Tefara E; Tinsley E; Groah S
PM R; 2018 Apr; 10(4):373-381. PubMed ID: 28827206
[TBL] [Abstract][Full Text] [Related]
11. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Syndrome in Male Survivors of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Total Body Irradiation, Low-Grade Inflammation, and Hypogonadism.
Muhic E; Mathiesen S; Nielsen MM; Suominen A; Sørensen K; Ifversen M; Nolsöe RL; Pedersen KM; Lähteenmäki P; Nordestgaard BG; Juul A; Jahnukainen K; Müller K
Transplant Cell Ther; 2021 Sep; 27(9):778.e1-778.e8. PubMed ID: 34091072
[TBL] [Abstract][Full Text] [Related]
14. IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial.
Ebrahimi F; Urwyler SA; Straumann S; Doerpfeld S; Bernasconi L; Neyer P; Schuetz P; Mueller B; Donath MY; Christ-Crain M
J Clin Endocrinol Metab; 2018 Sep; 103(9):3466-3476. PubMed ID: 29939279
[TBL] [Abstract][Full Text] [Related]
15. The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.
Khanal N; Ahmed SS; Kalra M; Miller TJ; Brames MJ; Stump TE; Monahan P; Hanna NH; Einhorn LH
Support Care Cancer; 2020 Jul; 28(7):3165-3170. PubMed ID: 31707501
[TBL] [Abstract][Full Text] [Related]
16. Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition.
IJpma I; Renken RJ; Gietema JA; Slart RH; Mensink MG; Lefrandt JD; Ter Horst GJ; Reyners AK
Appetite; 2016 Oct; 105():392-9. PubMed ID: 27298084
[TBL] [Abstract][Full Text] [Related]
17. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.
Lackner JE; Koller A; Schatzl G; Marberger M; Kratzik C
Urology; 2009 Oct; 74(4):825-9. PubMed ID: 19589582
[TBL] [Abstract][Full Text] [Related]
18. Relationship between insulin and hypogonadism in men with metabolic syndrome.
Caldas AD; Porto AL; Motta LD; Casulari LA
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):1005-11. PubMed ID: 20126854
[TBL] [Abstract][Full Text] [Related]
19. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD
Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
Zaid MA; Gathirua-Mwangi WG; Fung C; Monahan PO; El-Charif O; Williams AM; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse SK; Ardeshir-Rouhani-Fard S; Dinh PC; Sesso HD; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2018 Mar; 16(3):257-265. PubMed ID: 29523664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
